Learn More About the PROSERA Study
Now enrolling: The PROSERA phase 3 study of seralutinib in adults with pulmonary arterial hypertension.
Quantitative Immunohistochemistry of PDGFRα, PDGFRβ, c-KIT and CSF1R in Human PAH Lung Samples
